Vitura Health Limited
Vitura Health Limited (VIT.AX) Financial Performance & Income Statement Overview
Access detailed quarterly and annual financial reports for Vitura Health Limited (VIT.AX), covering cash flow, earnings, and balance sheets.
Vitura Health Limited (VIT.AX) Income Statement & Financial Overview
Analyze Vitura Health Limited’s VIT.AX earnings with segmented quarterly and yearly financial statement figures.
| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|
| Revenue | $63.90M | $59.97M | $59.70M | $29.85M |
| Cost of Revenue | $47.29M | $51.82M | $47.86M | $19.97M |
| Gross Profit | $16.60M | $8.16M | $11.84M | $9.88M |
| Gross Profit Ratio | $0.26 | $0.14 | $0.20 | $0.33 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $16.35M | $3.54M | $3.23M | $5.57M |
| Operating Expenses | $16.35M | $3.54M | $3.23M | $5.64M |
| Total Costs & Expenses | $63.65M | $55.36M | $51.09M | $25.61M |
| Interest Income | $656136.00 | $341804.00 | $268443.00 | $174602.00 |
| Interest Expense | $1.14M | $299827.00 | $110774.00 | $0.00 |
| Depreciation & Amortization | $227170.00 | $660659.00 | $443133.00 | $84760.00 |
| EBITDA | $475488.00 | $5.62M | $9.38M | $4.39M |
| EBITDA Ratio | $0.007 | $0.09 | $0.15 | $0.15 |
| Operating Income | $248320.00 | $4.62M | $8.61M | $4.31M |
| Operating Income Ratio | $0.004 | $0.08 | $0.14 | $0.14 |
| Other Income/Expenses (Net) | -$438620.00 | $40609.00 | $218377.00 | $109189.00 |
| Income Before Tax | -$190300.00 | $4.66M | $8.83M | $4.41M |
| Income Before Tax Ratio | -$0.003 | $0.08 | $0.15 | $0.15 |
| Income Tax Expense | -$446608.00 | $1.54M | $2.74M | $1.37M |
| Net Income | $242712.00 | $3.27M | $6.13M | $3.06M |
| Net Income Ratio | $0.004 | $0.05 | $0.10 | $0.10 |
| EPS | $0.00 | $0.006 | $0.01 | $0.005 |
| Diluted EPS | $0.00 | $0.006 | $0.01 | $0.005 |
| Weighted Avg Shares Outstanding | $591.98M | $564.05M | $556.53M | $567.67M |
| Weighted Avg Shares Outstanding (Diluted) | $589.55M | $568.52M | $571.55M | $571.60M |
Over the last four quarters, Vitura Health Limited's revenue moved from $29.85M in Q3 2023 to $63.90M in Q4 2024. Operating income in Q4 2024 was $248320.00, with a strong operating margin of 0%. Despite fluctuations in R&D and SG&A expenses, EBITDA for Vitura Health Limited remained robust at $475488.00, reflecting operational efficiency. Net income dropped to $242712.00, with an EPS of $0.00. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan